Currently Open Funding Opportunity Announcements Relevant to Healthcare Delivery Research

This page includes currently open Funding Opportunity Announcements (FOAs) sponsored or co-sponsored by HDRP; other FOAs relevant to HDRP; and NIH and NCI Parent and Omnibus FOAs for investigator-initiated research. Descriptions of the most commonly used grant mechanisms can be found on the NIH Grants & Funding pagesExternal Web Site Policy and full FOA presentations are available on the FOA webinars page. If you have questions about a grant application, please contact the NCI Program Director listed on the FOA.

FOAs Sponsored or Co-Sponsored by HDRP

Announcement Title Announcement Number
(Mechanism)
Expiration Date Program Contact
Optimizing the Management and Outcomes for Cancer Survivors Transitioning to Follow-up Care (R01 Clinical Trial Required) RFA-CA-19-035 (R01 Clinical Trial Required)External Web Site Policy
June 29, 2019 Michelle Mollica
240-276-7621
michelle.mollica@nih.gov
Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake PAR-18-008 (R01 Clinical Trial Optional)External Web Site Policy
PAR-16-337 (R03)External Web Site Policy
PAR-18-019 (R21 Clinical Trial Optional)External Web Site Policy
July 6, 2019 (R01)
July 17, 2019 (R03 and R21)
Sarah Kobrin
240-276-6931
kobrins@mail.nih.gov
Advanced-Stage Development and Utilization of Research Infrastructure for Interdisciplinary Aging Studies PAR-16-368 (R33)External Web Site Policy September 8, 2019 Erica Breslau
240-276-6773
breslaue@mail.nih.gov
Research Infrastructure Development for Interdisciplinary Aging Studies PAR-16-367 (R21)External Web Site Policy September 8, 2019 Erica Breslau
240-276-6773
breslaue@mail.nih.gov
Methodology and Measurement in the Behavioral and Social Sciences PAR-18-352 (R01 Clinical Trial Optional)External Web Site Policy
PAR-18-378 (R21 Clinical Trial Optional)External Web Site Policy
September 8, 2019 Sandra Mitchell
240-276-6929
mitchellsa@cc.nih.gov
Improving Outcomes for Pediatric, Adolescent and Young Adult Cancer Survivors RFA-CA-19-033External Web Site Policy (U01 Clinical Trial Required) January 4, 2020 Sandra Mitchell
240-276-6929
mitchlls@mail.nih.gov
Reducing Overscreening for Breast, Cervical, and Colorectal Cancers among Older Adults PA-18-005 (R01 Clinical Trial Optional)External Web Site Policy
PA-18-015 (R21 Clinical Trial Optional)External Web Site Policy
January 8, 2020 Erica Breslau
240-276-6773
breslaue@mail.nih.gov
Palliative Care Needs of Individuals with Rare Advanced Diseases and Their Family Caregivers PA-18-149 (R01 Clinical Trial Optional)External Web Site Policy
PA-18-167 (R21 Clinical Trial Optional)External Web Site Policy
January 8, 2020 Michelle Mollica
240-276-7621
michelle.mollica@nih.gov
Oral Anticancer Agents: Utilization, Adherence, and Health Care Delivery PA-18-004 (R01 Clinical Trial Optional)External Web Site Policy
PA-18-014 (R21 Clinical Trial Optional)External Web Site Policy
January 8, 2020 Wendy Nelson
240-276-6971
nelsonw@mail.nih.gov
Multilevel Interventions in Cancer Care Delivery: Follow-up to Abnormal Screening Tests PA-17-495 (R01 Clinical Trial Optional)External Web Site Policy
January 8, 2021 Erica Breslau
240-276-6773
breslaue@mail.nih.gov
Using Information Technology to Support Systematic Screening and Treatment of Depression in Cancer PA-18-492External Web Site Policy (R21 Clinical Trial Optional)
PA-18-493External Web Site Policy (R01 Clinical Trial Optional)
May 8, 2021 Gurvaneet Randhawa
240-276-6940
gurvaneet.randhawa@nih.gov
Increasing Uptake of Evidence-Based Screening in Diverse Adult Populations (R01 Clinical Trial Optional) PA-18-932External Web Site Policy January 8, 2022 Erica Breslau
240-276-6773
breslaue@mail.nih.gov
End-of-Life and Palliative Needs of Adolescents and Young Adults (AYA) with Serious Illnesses PAR-19-136 (R01 Clinical Trial Optional)External Web Site Policy
PAR-19-153 (R21 Clinical Trial Optional)External Web Site Policy
January 8, 2022 Ashley Wilder Smith
240-276-7621
smithas@mail.nih.gov

Other FOAs Relevant to HDRP

Announcement Title Announcement Number
(Mechanism)
Expiration Date Program Contact
Dissemination and Implementation Research in Health PAR-19-274 (R01)External Web Site Policy
PAR-19-275 (R21)External Web Site Policy
PAR-19-276 (R03)External Web Site Policy
May 8, 2022 Gila Neta
240-276-6785
netagil@mail.nih.gov

Wynne E. Norton, Ph.D.
National Cancer Institute (NCI)
240-276-6875
Wynne.Norton@nih.gov

David Chambers
240-276-5090
dchamber@mail.nih.gov
Cancer-Related Behavioral Research through Integrating Existing Data PAR-16-256 (R01)External Web Site Policy
PAR-16-255 (R21)External Web Site Policy
June 15, 2019 Rick Moser
240-276-6915
moserr@mail.nih.gov
Addressing Health Disparities through Effective Interventions Among Immigrant Populations PA-18-284 (R01 Clinical Trial Optional)External Web Site Policy
PA-18-285 (R21 Clinical Trial Optional)External Web Site Policy
January 8, 2020 Shobha Srinivasan
240-276-6938
ss688k@nih.gov
Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)

Research to Improve Native American Health (R21 Clinical Trials Optional)
PAR-17-496 (R01)External Web Site Policy

PAR-17-464 (R21)External Web Site Policy
May 15, 2020 Shobha Srinivasan
240-276-6938
ss688k@nih.gov

NIH and NCI Parent and Omnibus FOAs for Investigator-Initiated Research

Announcement Title Announcement Number
(Mechanism)
Expiration Date
NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed) PA-18-484 (R01) External Web Site Policy January 8, 2021
Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required) PAR-18-559External Web Site Policy January 8, 2021
Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional) PAR-18-869External Web Site Policy March 9, 2021

Visit https://grants.nih.gov/grants/guide/parent_announcements.htmExternal Web Site Policy for a full list of all NIH parent announcements.

Last Updated: 12 Jun, 2019